These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 18983342)

  • 1. Re-irradiation with concurrent chemotherapy in recurrent head and neck cancer: a decision analysis model based on a systematic review.
    Paleri V; Kelly CG
    Clin Otolaryngol; 2008 Aug; 33(4):331-7. PubMed ID: 18983342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Locally recurrent, previously irradiated head and neck cancer: concurrent re-irradiation and chemotherapy, or chemotherapy alone?
    Wong SJ; Machtay M; Li Y
    J Clin Oncol; 2006 Jun; 24(17):2653-8. PubMed ID: 16763279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concurrent chemotherapy and re-irradiation for locoregionally recurrent head and neck cancer.
    Salama JK; Vokes EE
    Semin Oncol; 2008 Jun; 35(3):251-61. PubMed ID: 18544440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review on re-irradiation for recurrent and second primary head and neck cancer.
    Kasperts N; Slotman B; Leemans CR; Langendijk JA
    Oral Oncol; 2005 Mar; 41(3):225-43. PubMed ID: 15743686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of radiation therapy for the control of Merkel cell carcinoma of the head and neck based on 36 cases and a literature review.
    Lawenda BD; Arnold MG; Tokarz VA; Silverstein JR; Busse PM; McIntyre JF; Deschler DG; Baldini EH; Kachnic LA
    Ear Nose Throat J; 2008 Nov; 87(11):634-43. PubMed ID: 19006065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Re-irradiation in the management of isolated neck recurrences: current status and recommendations.
    Chopra S; Gupta T; Agarwal JP; Budrukkar A; Ghosh-Laskar S; Dinshaw K
    Radiother Oncol; 2006 Oct; 81(1):1-8. PubMed ID: 16971009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes following reirradiation of patients with head and neck cancer.
    Goldstein DP; Karnell LH; Yao M; Chamberlin GP; Nguyen TX; Funk GF
    Head Neck; 2008 Jun; 30(6):765-70. PubMed ID: 18286493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality-of-life considerations in treatment of unresectable, recurrent head and neck cancer.
    McLarnon C; Kulloo P; Mehanna H; Kelly C; Paleri V
    Expert Rev Anticancer Ther; 2010 Mar; 10(3):345-52. PubMed ID: 20214516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic chemotherapy with cisplatin plus 5-FU (PF) for recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN): efficacy and safety of a lower dose of PF (80/800) at a single institution in Japan.
    Kiyota N; Tahara M; Kadowaki S; Fuse N; Doi T; Minami H; Ohtsu A
    Jpn J Clin Oncol; 2009 Apr; 39(4):225-30. PubMed ID: 19211574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Illness and treatment beliefs in head and neck cancer: is Leventhal's common sense model a useful framework for determining changes in outcomes over time?
    Llewellyn CD; McGurk M; Weinman J
    J Psychosom Res; 2007 Jul; 63(1):17-26. PubMed ID: 17586334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of palliative radiotherapy in advanced head and neck cancer.
    Hodson DI; Bruera E; Eapen L; Groome P; Keane T; Larsson S; Pearcey R
    Can J Oncol; 1996 Feb; 6 Suppl 1():54-60. PubMed ID: 8853539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypofractionated radiotherapy denoted as the "Christie scheme": an effective means of palliating patients with head and neck cancers not suitable for curative treatment.
    Al-mamgani A; Tans L; Van rooij PH; Noever I; Baatenburg de jong RJ; Levendag PC
    Acta Oncol; 2009; 48(4):562-70. PubMed ID: 19373698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of salvage selective and modified radical neck dissection for regional pathologic lymphadenopathy after chemoradiation.
    van der Putten L; van den Broek GB; de Bree R; van den Brekel MW; Balm AJ; Hoebers FJ; Doornaert P; Leemans CR; Rasch CR
    Head Neck; 2009 May; 31(5):593-603. PubMed ID: 19132716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of pain in head and neck cancer recurrence and survivorship.
    Scharpf J; Karnell LH; Christensen AJ; Funk GF
    Arch Otolaryngol Head Neck Surg; 2009 Aug; 135(8):789-94. PubMed ID: 19687400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting regional control based on pretreatment nodal size in squamous cell carcinoma of the head and neck treated with chemoradiotherapy: a clinician's guide.
    Porceddu SV; Sidhom M; Foote M; Burmeister E; Stoneley A; El Hawwari B; Milross C; Kenny L; Poulsen M; Coman WB
    J Med Imaging Radiat Oncol; 2008 Oct; 52(5):491-6. PubMed ID: 19032396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controversies in surgical management of the node-positive neck after chemoradiation.
    Lango MN; Myers JN; Garden AS
    Semin Radiat Oncol; 2009 Jan; 19(1):24-8. PubMed ID: 19028342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postoperative reirradiation for mucosal head and neck squamous cell carcinomas.
    Iseli TA; Iseli CE; Rosenthal EL; Caudell JJ; Spencer SA; Magnuson JS; Smith AN; Carroll WR
    Arch Otolaryngol Head Neck Surg; 2009 Nov; 135(11):1158-64. PubMed ID: 19917931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New chemoradiotherapy combinations in head and neck cancer.
    Busto G; Corvò R; Ricci I; Sanguineti G; Benasso M
    Expert Rev Anticancer Ther; 2001 Jun; 1(1):111-5. PubMed ID: 12113117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors for survival after salvage reirradiation of head and neck cancer.
    Tanvetyanon T; Padhya T; McCaffrey J; Zhu W; Boulware D; Deconti R; Trotti A
    J Clin Oncol; 2009 Apr; 27(12):1983-91. PubMed ID: 19289616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PET-CT in recurrent head neck cancers: a study to evaluate impact on patient management.
    Pantvaidya GH; Agarwal JP; Deshpande MS; Rangarajan V; Singh V; Kakade A; D'Cruz AK
    J Surg Oncol; 2009 Oct; 100(5):401-3. PubMed ID: 19235784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.